+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 AIDS Related Cancer Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4767494
  • Report
  • April 2019
  • Region: Global
  • 54 pages
  • VPA Research
1 of 3

FEATURED COMPANIES

  • BioNTech AG
  • Celgene Corp
  • F. Hoffmann-La Roche Ltd
  • Novartis AG
  • Sanofi
  • The EMMES Corp
  • MORE
The global clinical trial report- “2019 AIDS Related Cancer Clinical Trials Study” provides complete list of trials completed, ongoing and planned for AIDS Related Cancer. It presents in-depth analysis of AIDS Related Cancer clinical trials across markets and companies. The research work is for providing complete understanding into trends in AIDS Related Cancer.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the AIDS Related Cancer clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of AIDS Related Cancer

The research work is prepared through extensive and continuous research on AIDS Related Cancer trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering AIDS Related Cancer patients are identified
  • The report includes panorama of AIDS Related Cancer clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on AIDS Related Cancer clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • BioNTech AG
  • Celgene Corp
  • F. Hoffmann-La Roche Ltd
  • Novartis AG
  • Sanofi
  • The EMMES Corp
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 AIDS Related Cancer Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 AIDS Related Cancer Clinical Trials by Region
2.2.2 Average Enrollment of AIDS Related Cancer Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for AIDS Related Cancer Treatment, 2019

3. Region wise AIDS Related Cancer Clinical Trials
3.1 Asia Pacific AIDS Related Cancer Clinical Trials by Country
3.2 Europe AIDS Related Cancer Clinical Trials by Country
3.3 North America AIDS Related Cancer Clinical Trials by Country
3.4 Middle East and Africa AIDS Related Cancer Clinical Trials by Country
3.5 South and Central America AIDS Related Cancer Clinical Trials by Country

4. AIDS Related Cancer Clinical Trial Trends
4.1 Start Year wise AIDS Related Cancer Clinical Trials
4.2 Phase wise AIDS Related Cancer Clinical Trials
4.3 Trial Status wise AIDS Related Cancer Clinical Trials
4.4 Trial Type wise AIDS Related Cancer Clinical Trials

5. AIDS Related Cancer Average Enrollment Trends
5.1 Average Enrollment in AIDS Related Cancer Trials by Year
5.2 Average Enrollment in AIDS Related Cancer Trials by Phase
5.3 Average Enrollment in AIDS Related Cancer Trials by Status
5.4 Average Enrollment in AIDS Related Cancer Trials by Type of Trial

6. Companies Participating in AIDS Related Cancer Clinical Trials
6.1 AIDS Related Cancer Trials by Sponsor Type
6.2 AIDS Related Cancer Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 AIDS Related Cancer Trials- Phase 1
7.2 AIDS Related Cancer Trials- Phase 2
7.3 AIDS Related Cancer Trials- Phase 3
7.4 AIDS Related Cancer Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: AIDS Related Cancer Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise AIDS Related Cancer Clinical Trials and Enrolment
Figure 5: Europe - Country wise AIDS Related Cancer Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise AIDS Related Cancer Clinical Trials and Enrolment
Figure 7: North America - Country wise AIDS Related Cancer Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise AIDS Related Cancer Clinical Trials and Enrolment
Figure 9: AIDS Related Cancer Clinical Trials by Phase
Figure 10: AIDS Related Cancer Clinical Trials by Trial Status
Figure 11: AIDS Related Cancer Clinical Trials by Type
Figure 12: AIDS Related Cancer Clinical Trials by Sponsor Type
Figure 13: AIDS Related Cancer Clinical Trials by Leading Sponsors
Figure 14: AIDS Related Cancer Average Enrollment by Phase
Figure 15: AIDS Related Cancer Average Enrollment by Trial Status
Figure 16: AIDS Related Cancer Average Enrollment by Type
Figure 17: AIDS Related Cancer- Average Enrolment by Type of Sponsors
Figure 18: AIDS Related Cancer- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: AIDS Related Cancer Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise AIDS Related Cancer Clinical Trials and Enrolment
Table 5: Europe - Country wise AIDS Related Cancer Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise AIDS Related Cancer Clinical Trials and Enrolment
Table 7: North America - Country wise AIDS Related Cancer Clinical Trials and Enrolment
Table 8: South and Central America - Country wise AIDS Related Cancer Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: AIDS Related Cancer Average Enrollment by Phase
Table 15: AIDS Related Cancer Average Enrollment by Trial Status
Table 16: AIDS Related Cancer Average Enrollment by Type
Table 17: AIDS Related Cancer- Average Enrolment by Type of Sponsors
Table 18: AIDS Related Cancer- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 3
  • BioNTech AG
  • Celgene Corp
  • CSL Behring Australia Pty Ltd
  • F. Hoffmann-La Roche Ltd
  • Ligand Pharmaceuticals Inc
  • Novartis AG
  • Sanofi
  • Sequus Pharmaceuticals Inc
  • The EMMES Corp
  • ViroStatics srl
Note: Product cover images may vary from those shown
Adroll
adroll